Skip to main content
. 2014 Nov 11;349:g6419. doi: 10.1136/bmj.g6419

graphic file with name bans021664.f6_default.jpg

Fig 6 Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitor from a direct comparison analysis for the outcomes of (a) major bleeding, and (b) minor bleeding